Although febrifugine (1) and isofebrifugine (2), alkaloids isolated from roots of the Dichroa
febrifuga plant, show powerful antimalarial activity against Plasmodium falciparum, strong
side effects such as the emetic effect have precluded their clinical use against malaria. However,
their antimalarial potency makes them attractive substances as leads for developing new types
of chemotherapeutic antimalarial drugs. Thus, we have evaluated the in vitro antimalarial
activity of the analogues of febrifugine (1) and isofebrifugine (2). The activities of the analogues
derived from Df-1 (3) and Df-2 (4), condensation products of 1 and 2 with acetone, respectively,
were also obtained. The 3‘ ‘-keto derivative (7, EC50 = 2.0 × 10-8 M) of 1 was found to exhibit
potential antimalarial activity with high selectivity against P. falciparum in vitro. The in vitro
activities of the reduction product (8, EC50 = 2.0 × 10-8 M) of 1 at C-2‘ and its cyclic derivatives
9 and 10 (EC50 = 3.7 × 10-9 and 8.6 × 10-9 M, respectively) were found to be strongly active
and selective. Additionally, the Dess−Martin oxidation product of 3 was found to be strongly
active with high selectivity against P. falciparum. A structure−activity relationship study (SAR)
demonstrates that the essential role played by the 4-quinazolinone ring in the appearance of
activity and the presence of a 1‘ ‘-amino group and C-2‘, C-3‘ ‘ O-functionalities are crucial in
the activity of 1. For 7, 8, and 9, prepared as racemic forms, an in vivo study has also been
conducted.